Weak Link in the Pharmaceutical Supply Chain
The recent heparin contamination event calls for a new approach to manage a lengthening pharmaceutical supply chain.
Globalizing Drug Development
Increased investment by the pharmaceutical and biotechnology majors in offshore early drug development creates opportunities and challenges for outsourcing.
Will REACH Reach the US?
Congress is considering proposing a new chemical policy similar to the European Union’s REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation. Batch and custom manufacturers weigh in on the debate.
